January 19, 2022
GlaxoSmithKline LLC urged a Florida magistrate judge on Wednesday to allow it to get more information from pharmacy Valisure LLC in multidistrict litigation over alleged links between the heartburn drug Zantac and various cancers, arguing that Valisure's initial testing of the drug and citizen petition to the U.S. Food and Drug Administration "permeates through the case."
October 25, 2021
The parties in sprawling multidistrict litigation over alleged links between the heartburn drug Zantac and various cancers presented a joint plan Monday for narrowing a field of more than 130,000 potential personal injury claimants to serve as plaintiffs in initial bellwether trials targeted for 2023.
October 07, 2021
A Florida federal judge won't let drugmakers escape claims from a class alleging that their use of Zantac and its generics have given them an increased risk of cancer, saying the class members don't need to specify their particular level of exposure to carcinogens to keep their suit afloat.
October 04, 2021
Drugmakers targeted in multidistrict litigation over a carcinogen found in heartburn medication Zantac urged a Florida federal court Monday to toss medical monitoring claims, arguing that the plaintiffs have failed again to specify levels of the carcinogen that would cause an increased cancer risk.
August 24, 2021
Manufacturers and retailers of the heartburn medication Zantac urged a Florida federal judge on Monday to dismiss the medical monitoring claims of a class of consumers in multidistrict litigation because they had failed to show that their exposure to the carcinogen in the drug was enough to increase their risk of cancer.
July 09, 2021
A Florida federal judge dismissed all claims against manufacturers of the generic form of the heartburn medication Zantac and retailers in sprawling multidistrict litigation alleging the drug contains a known carcinogen, finding that all claims are preempted by federal law.
July 01, 2021
A Florida federal judge on Wednesday cut loose retailers and pharmacies from multidistrict litigation over the heartburn medication Zantac, ruling that consumers' claims that the companies' negligence played a part in a carcinogen forming in the drug were implausibly claimed.
June 04, 2021
Retailers and generics manufacturers asked a Florida federal court Friday to let them exit a multidistrict litigation over heartburn medication Zantac, arguing they're the wrong targets for the claims regarding a carcinogen found in the drug.
June 03, 2021
Consumers suing drugmakers and others in a multidistrict litigation over a carcinogen found in heartburn medication Zantac fought Thursday in Florida federal court to keep their claims alive as the defendants argued their claims lacked specificity or an actual injury.
January 11, 2021
A Florida federal judge presiding over sprawling multidistrict litigation involving the carcinogens found in the heartburn medication Zantac cut more claims on Friday from the litigation, holding that design defect claims are barred by federal law.